#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oropharyngeal squamous cell carcinoma Rett syndrome Neonatal asphyxia Biotinidase deficiency Chordoma Allogenic stem cell transplantation Primary amyloidosis Polymyositis Neuroblastoma Follicular lymphoma stage I Acute lymphocytic leukaemia recurrent Hypersomnia Atopic keratoconjunctivitis Erythema multiforme Leukodystrophy More trials…

    Learn about Rare Diseases

    Proteus syndrome Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Indolent systemic mastocytosis – Diagnostics KBG syndrome – Trials in Disease Thrombotic thrombocytopenic purpura – Treatment Wolfram syndrome Methylmalonic acidaemia IgA nephropathy – Life with Disease Familial amyotrophic lateral sclerosis Synovial sarcoma metastatic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gad20-209-Fsp-A2 Poa Pratensis Pollen Extract Human Albumin Solution Lactic Acid CHOLINE ALFOSCERATE Metyrapone Bp Arrhenatherum Elatius Meclofenamate Sodium Ipatasertib Ioversol Human Serum Albumin 5% Chloroprocaine Hydrochloride Metformin Embonate Calcium Folinate Mesenchymal Cells Bms-986435 Eftilagimod Alfa Iopromide Opium, Standardized Powdered SEVABERTINIB More therapies…

    Learn about Your Condition

    Oral neoplasm Large cell lung cancer Essential thrombocythaemia Premature rupture of membranes Cystic fibrosis lung Depression Netherton's syndrome Arthroscopy Psychotic disorder Behcet's syndrome Psychogenic seizure Coeliac disease Vulval cancer Rett syndrome Systemic candida More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Gastrooesophageal reflux disease

  • Study on Omeprazole and Cow’s Milk-Free Diet for Treating Gastroesophageal Reflux Disease in Infants Under 1 Year

    Recruiting

    3 1 1
    Investigated Diseases:
    • Milk allergy
    • Gastrooesophageal reflux disease
    Investigated Drugs:
    • Omeprazole
    Denmark

  • Study of prucalopride in patients with gastro-esophageal reflux disease who have incomplete response to standard acid-reducing therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Gastrooesophageal reflux disease
    Investigated Drugs:
    • Prucalopride
    Belgium

  • Study on Citalopram for Patients with Reflux Hypersensitivity or Functional Heartburn Not Fully Helped by Proton Pump Inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Gastrooesophageal reflux disease
    Investigated Drugs:
    • Citalopram
    Belgium

  • Study of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lansoprazole
    • LINAPRAZAN GLURATE
    Bulgaria Czechia Germany Hungary Poland Romania

  • Comparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lansoprazole
    • LINAPRAZAN GLURATE
    Bulgaria Czechia Germany Hungary Poland Romania

  • Safety Study of Almagate for Pregnant Women with Heartburn and Reflux, Assessing Effects on Mother and Baby

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dyspepsia
    • Gastrooesophageal reflux disease
    Investigated Drugs:
    • Almagate
    Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!